Company Announcements

DKSH signed in March an exclusive marketing, sales, distribution and after-sales service agreement with China-based Rigol Scientific for Malaysia for HPLC systems and UV-Vis spectrometers.

Phenomenex announced in April that its Indian business grew 15% in 2015.

Analytik Jena announced in April the sale of its Optics business to NOBLEX, a subsidiary of VF Capital. The sale includes optical consumer products sold under the DOCTER brand, as well as the production of parts, assemblies and components used in analytical technologies. NOBLEX will continue to produce the parts.

In 2015, Endress+Hauser sales rose 6.5% to €2.1 billion ($2.3 billion). The company created a sales structure for Analytik Jena in Canada, South Korea and Switzerland.

BioMérieux Industrial Applications sales rose 4.1%, 6.1% in constant currency, to €86.0 million ($94.5 million) in the first quarter, led by sales of microbiology product lines and VIDAS, which offset the discontinuation of certain products.

GE Healthcare announced that Life Sciences revenue grew 6%, 13% organically, in the first quarter. Life Sciences orders rose 7% organically, with bioprocess orders up 7%.

Xylem modified its agreement with Lab Synergy, formerly the exclusive North American distributor of its titration products. YSI, a Xylem brand, will now sell SI Analytics titration and viscometry products. OI Analytical, another Xylem brand, will now sell C. Gerhardt products, which were previously distributed by Lab Synergy.

PerkinElmer and the Genome Institute of Singapore (GIS) opened the PerkinElmer–GIS Centre for Precision Oncology, which aims to develop an HTS platform to predict therapeutic sensitivity in next generation patient-derived tumor models in real time.

Ryuichi Kitayama will retire from Hitachi High-Technologies’ Board in June.

Canada’s York University announced the launch of the “Technology-Enhanced Biopharmaceuticals Development and Manufacturing” initiative, in partnership with Sanofi-Pasteur, SCIEX and Fluidigm. SCIEX will provide MS instruments, and Fluidigm will provide its CyTOF technology.

Eppendorf’s 2015 sales rose 18.5%, 7.1% in constant currency, to €629.1 million ($699.0 million) (see IBO 4/30/16). Adjusted operating income grew 22.0% to €123.2 million ($136.9 million). North/South American sales rose 27.4%, 7.8% in constant currency, to make up 39% of sales. European sales grew 7.2%, 4.7% in constant currency, to represent 37%. Sales in Asia/Pacific/Africa increased 24.2%, 7.1% in constant currency, to make up 25%.

Dr. Shilin Chen, director of the Institute of Chinese Materia Medica at the China Academy of Chinese Medical Sciences, received an Agilent Thought Leader Award in April for his herbal genomics research using multi-omics techniques.